saridegib (IPI-926)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for saridegib (IPI-926), covering 2013-12-05 to 2013-12-05. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma [Phase 2]